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Abstract
Background: Microarrays are an invaluable tool in many modern genomic studies. It is generally
perceived that decreasing the size of microarray features leads to arrays with higher resolution
(due to greater feature density), but this increase in resolution can compromise sensitivity.
Results: We demonstrate that barcode microarrays with smaller features are equally capable of
detecting variation in DNA barcode intensity when compared to larger feature sizes within a
specific microarray platform. The barcodes used in this study are the well-characterized set derived
from the Yeast KnockOut (YKO) collection used for screens of pooled yeast (Saccharomyces
cerevisiae) deletion mutants. We treated these pools with the glycosylation inhibitor tunicamycin as
a test compound. Three generations of barcode microarrays at 30, 8 and 5 μm features sizes
independently identified the primary target of tunicamycin to be ALG7.
Conclusion: We show that the data obtained with 5 μm feature size is of comparable quality to
the 30 μm size and propose that further shrinking of features could yield barcode microarrays with
equal or greater resolving power and, more importantly, higher density.
Background
Genome-wide studies often measure changes in the abun-
dance of all gene products over a period of time or under
varying conditions. Microarrays have made these studies
possible by enabling researchers to monitor all known
genes of an organism simultaneously to detect patterns of
gene activity [1], alternative splicing variants [2] the pres-
ence of single nucleotide polymorphisms [3], the pres-
ence of copy number variants and [4] DNA binding sites
of diverse proteins [5], among others. One application of
microarrays that our laboratory has focused on is the par-
allel identification of individual molecular barcoded gene
deletion mutants grown competitively in pools [6,7].
Through the efforts of the Yeast Deletion Consortium, a
Yeast KnockOut (YKO) collection was constructed con-
sisting of approximately 6,000 heterozygous gene dele-
tions (>96% of all annotated open reading frames), of
which over 1,100 are known to be essential for growth [7].
The remaining ~5,000 genes are nonessential, created as
homozygous deletions and MATαand MATα deletion col-
lections. These collections were made by systematic
replacement of each gene from start to stop codon by
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mitotic recombination with a molecular barcoded resist-
ance cassette. Each cassette contains both an upstream
barcode (uptag) and a downstream barcode (downtag)
that differ in their 20-mer sequence [7]. Drug sensitivity
assays, combined with DNA barcode microarrays, were
able to reveal genomic profiles for both the drug's targets
through Haplo  Insufficiency  Profiling (HIP) and path-
ways that buffer the drug target pathway through
HOmozygous deletion Profiling (HOP) [8,9].
Microarrays are made up of thousands to millions of
microscopic "features", clusters of identical oligonucle-
otide probes, which are used to detect hybridized gene
products. The microarrays used for HIPHOP assays have
gone through several iterations of development, begin-
ning with a feature size of 103 μm on the TAG1 array
which consisted of 20 bp (base pair) probes [6,8]. The S.
cerevisiae  cassette was originally designed for detection
using the TAG1 microarray, which used 20 bp-long oligo-
nucleotide probes. Current Affymetrix microarrays use up
to 25 bp probes to detect complementary DNA sequences,
and this length is more appropriate for newer barcoded
collections as it improves hybridization specificity and
increases the number of resolvable potential barcodes
[10]. The features on these chips were subsequently mini-
aturized to 30 μm and provided full deletion pool cover-
age on the TAG3 array (P/N 510318) [7]. The current
TAG4 chips (P/N 511331) with 8 μm feature sizes were
designed for improved performance and affordability.
This scheme omitted uninformative probes present on
previous tag arrays and added five replicates to report
non-uniform hybridization and allow adjustment of
intensities accordingly [11]. No smaller yeast deletion
pool barcode microarray exists due to manufacturing size
constraints, however, these barcode probes are also
present on the 5 μm yeast whole genome tiling array
(S288c genome tiling microarray; P/N 520055) represent-
ing 0.25% of the total 6.5 million probes on this array
[12]. The area of the features scale quadratically, such that
the tiling array features at 5 μm on a side correspond to 25
μm2, and TAG3 features at 30 μm on a side correspond to
900 μm2, or 36 times the area of the tiling features. It is
important to note that all arrays have the same oligonu-
cleotide probe density of approximately 4,000 probes/
μm2 (personal communication with Affymetrix technical
support).
Methods
Yeast deletion pools were thawed from frozen stocks and
heterozygote essential gene deletion mutants were grown
for 20 generations, while homozygous deletion mutants
were grown for 5 generations as described [13]. After
growth, heterozygous essential deletion mutants were
mixed with correspondingly treated homozygous non-
essential deletion mutants. Genomic DNA was isolated
and molecular barcodes amplified by PCR. Amplicons
were then hybridized to microarrays over night, washed,
stained and scanned the following day. For further details
regarding sample preparation and data analysis, consult
Pierce et al [14] and Hoon et al [13].
We performed a HIPHOP screen (pooled heterozygous
essential strains and homozygous deletion non-essential
strains) with tunicamycin treatment (IC10-20 = 0.35 μM).
Tunicamycin is a known glycosylation inhibitor, targeting
the yeast essential gene ALG7  [15-17], which encodes
UDP-N-acetyl-glucosamine-1-P transferase, a vital protein
in the dolichol pathway of protein asparagine-linked gly-
cosylation [18,19]. Upon treatment with tunicamycin,
unfolded proteins remain in the ER (endoplasmic reticu-
lum) [20]. A sample treated with 2% DMSO was used as a
control. Yeast pools were grown in liquid culture in 48
well plates in a shaking spectrophotometer interfaced to
liquid handling robots. After the cells had grown for the
desired number of generations, corresponding to a spe-
cific optical density (OD), they were robotically harvested
[14]. Genomic DNA was isolated from each pool, and the
DNA barcodes were amplified by PCR using common
primers. These barcodes were subsequently hybridized to
three generations of barcode microarrays: the aforemen-
tioned TAG3, TAG4 and S. cerevisiae whole genome tiling
arrays. Each chip was prepared using the optimal hybridi-
zation and wash/stain protocols recommended for that
array type. Deletion strain abundance was resolved by
averaging scanned downtag and uptag intensities for each
strain and comparing intensities between the tunicamy-
cin-treated pool and the DMSO-treated pool [14] (see
Additional File 1).
Results and Discussion
All three microarray generations, the TAG3, TAG4 and S.
cerevisiae whole genome tiling arrays, identified ALG7 as
the primary target of tunicamycin, as expected (Figure 1).
The tiling array also identified several other genes as addi-
tional potential targets. This list of targets includes ADO1,
FYV8,  GET2,  HAC1  and  IRE1, all of which have been
shown to be sensitive to tunicamycin when knocked out,
as well as BCK1, a gene which has previously been shown
to be resistant to tunicamycin when overexpressed [19,21-
24]. In particular, ADO1 is a prime example of a gene
deletion strain exhibiting increased sensitivity on the til-
ing array, since it is detected at a log2 ratio of 2.59 in the
tiling array data, but at 0.50 and 0.66 in the TAG3 and
TAG4 data, respectively. In addition to known sensitive
strains, our screen identified COP1 and RER2, which are
involved in ER to Golgi vesicle-mediated transport (see
Table 1 for summary of sensitive strains) [25,26]. As with
most sensitive strains, these genes were detected at slightlyBMC Genomics 2009, 10:471 http://www.biomedcentral.com/1471-2164/10/471
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Identifying tunicamycin targets on three microarray generations Figure 1
Identifying tunicamycin targets on three microarray generations. Barcode intensity data are normalized according to 
a DMSO reference treatment. Blue dots represent non-essential genes, red dots represent essential genes and grey dots are 
genes that are not annotated. Log2 ratios are calculated as a measure of change in barcode intensity (vertical axis) across all 
genes (horizontal axis). Ratios below 0 have been removed for clarity. Log2 scales differ based on optimal dynamic range 
between baseline and ALG7. Higher ratios correspond to greater abundance of barcode from reference to treatment. In all 
three analyses, ALG7 was correctly identified as the primary target of tunicamycin. Several additional genes previously deter-
mined to be resistant to tunicamycin, were most discernibly identified in the tiling data, but less so using TAG4 (the current 
microarray standard) and TAG3. These include ADO1, BCK1, FYV8, GET2, HAC1 and IRE1. Furthermore, the genes COP1 and 
RER2, known to be involved in ER to Golgi vesicle-mediated transport, showed up as sensitive to tunicamycin in our screen.BMC Genomics 2009, 10:471 http://www.biomedcentral.com/1471-2164/10/471
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higher levels on the tiling array than on the other array
generations. The tiling array appears to have slightly
higher variance in its log2 ratios than the other arrays
(standard deviation of 0.58 in tiling, compared to 0.37
and 0.43 in TAG4 and TAG3 arrays, respectively). We
determined this to be due to its increased sensitivity to
hybridized barcode abundance since sometimes strains
that appear sensitive on the tiling array, fall into the back-
ground signal of the other arrays, as with ADO1. It is reas-
suring to observe both the primary target of tunicamycin
and genes annotated as sensitive to tunicamycin in our
results. Additionally, we also identified genes associated
with the endoplasmic reticulum and involved in the
unfolded protein response because tunicamycin pro-
motes protein misfolding.
Because the tiling array has millions of probes, only a few
thousand of which are barcode probes, we hypothesized
that non-specific hybridization of barcode DNA to the
genome tiling probes could potentially contribute to
noise in target identification. This may have been prob-
lematic because the tiling probes were not designed for
explicit use with the barcode probes, which could lead to
unanticipated cross-hybridization of barcode samples to
tiling probe features. To determine if non-specific binding
was a factor in our experiments, we co-hybridized barcode
DNA with unlabeled digested genomic DNA (gDNA). The
digested gDNA (20-150 bp) competitively hybridized to
tiling probes of the array to which barcodes may have had
a non-specific affinity. We asked if the addition of gDNA
could result in an increase of specific binding of barcodes
to barcode probes, yielding a HIPHOP profile with greater
Table 1: Gene targets of tunicamycin identified in the tiling array experiment.
ORF Gene Name GO Biological Process tunicamycin treatment relevance
YJR105W ADO1 purine base metabolic process knockout sensitive to tunicamycin [23]
YBR243C ALG7 protein amino acid N-linked glycosylation and others known target of tunicamycin [15-17]
YJL095W BCK1 endoplasmic reticulum unfolded protein response and others knockout sensitive [21-23], overexpressor resistant 
[21] to tunicamycin
YDL145C COP1 ER to Golgi vesicle-mediated transport and others involved in ER to Golgi vesicle-mediated transport 
[25]
YGR196C FYV8 unknown knockout sensitive to tunicamycin [21]
YER083C GET2 protein insertion into ER membrane and others knockout sensitive to tunicamycin [24]
YFL031W HAC1 specific RNA polymerase II transcription factor activity and 
others
knockout sensitive to tunicamycin [21,23]
YHR079C IRE1 endoplasmic reticulum unfolded protein response and others knockout sensitive to tunicamycin [21,23]
YOR246C N/A unknown unknown
YFL032W N/A unknown likely deletes HAC1 promoter [19]
YER010C N/A unknown interacts with kinases Ptk2, Tpk1 [30]
YMR308C PSE1 protein import into nucleus and others interacts with Ulp1, regulating ubiquitination [31]
YBR002C RER2 ER to Golgi vesicle-mediated transport and others involved in ER to Golgi vesicle-mediated transport 
[26]
YFR051C RET2 ER to Golgi vesicle-mediated transport and others interacts with Bre5, Hsc82, Hsp92 [31-33] which are 
involved in protein processing
YNL151C RPC31 transcription from RNA polymerase III promoter interacts with Mms1, Shp1, Ubi4, regulating 
ubiquitination [34,35]
YJR102C VPS25 ubiquitin-dependent protein catabolic process via the 
multivesicular body sorting pathway and others
involved in ubiquitin-dependent protein catabolism 
[36]BMC Genomics 2009, 10:471 http://www.biomedcentral.com/1471-2164/10/471
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dynamic range and more distinct targets (making the mil-
lions of tiling probes unavailable for barcode hybridiza-
tion) analogous to the addition of salmon or herring
sperm to a Southern blot to prevent non-specific hybridi-
zation [27,28]. However, in practice, we found that the
addition of gDNA did not improve resolution of the target
ALG7 when compared to a microarray without competi-
tive gDNA co-hybridization (Additional File 2).
Our initial experiments used protocols for each microar-
ray that were optimized for that particular technology. For
example, each array type has particular hybridization,
washing and staining protocols. To minimize the effect of
these subtle variations and to accurately compare inten-
sity data across array generations, we hybridized a refer-
ence sample (treated with 2% DMSO) to TAG3, TAG4 and
tiling microarrays and applied TAG4 wash protocols to
each array type. The hybridization conditions were fixed
so that we could be certain that any changes we observed
were attributed solely to feature size and not protocol var-
iation. We scanned the microarrays following this proto-
col, and subsequently applied the tiling array antibody
stain wash step to all three chips and, once again, scanned
them. In this manner, each array was treated identically.
In general, we observed median downtag intensity was
higher than median uptag intensity (Figure 2), an obser-
vation that was also reported by Pierce et al [11,14]. In
addition, the median intensities differed across genera-
tions, with TAG3 intensity lower than TAG4 intensity,
which was lower than tiling intensity.
We found that TAG4 and tiling array intensities were very
highly correlated (Tables 2 and 3; example in Figure 3).
This correlation increased slightly once the arrays had
been antibody stained during the tiling wash protocol. In
contrast, TAG3 intensities did not correlate as well with
either TAG4 or tiling, and this decreased significantly after
antibody staining. However, this low correlation is
unlikely to affect identification of drug targets on TAG3
arrays, as these strains are often the most distinguishable
from the background, as shown previously (Figure 1).
The relatively recent design of the TAG4 microarray
includes five replicates of each barcode probe [11]. How-
ever, we noticed that intensity values do not vary greatly
between these replicates, and, therefore, a minimum of
three replicates should be included to allow for appropri-
ate trim mean calculations and masking of unusable bar-
code probes [14]. This finding confirms an earlier
assertion by Pierce et al. that suggests that the minimum
number of replicates required to achieve high correlation
is three replicates, and that the increase in correlation
from the fourth and fifth replicates is marginal [11].
Although the TAG3 and tiling results contain only single
data points for each barcode and are able to determine
ALG7 as the primary target of tunicamycin (Figure 1), rep-
licate data points are advised to accommodate hybridiza-
tion, washing and staining inconsistencies.
Conclusion
Here we present a systematic comparison of the behavior
of 12,000 20 bp barcode probes at three feature sizes.
Counter to our expectation, we found that the smallest
features, representing less than 1/30 the space of the larg-
est features, perform best in terms of signal intensity and
in their ability to identify drug targets in complex pooled
A) Median intensity for all barcodes, including downtags,  uptags and unassigned barcodes (used to measure back- ground) Figure 2
A) Median intensity for all barcodes, including down-
tags, uptags and unassigned barcodes (used to meas-
ure background). Median is used due to non-normal 
intensity distributions (see B). Tiling intensities are consist-
ently higher than TAG4, which are higher than TAG3. This 
trend is intensified by the addition of antibody staining. 
Downtags are consistently higher than uptags, as previously 
described [14]. Background intensity on all three generations 
is similar. B) Distributions of downtag intensity. Downtag 
intensity axis is shown on a logarithmic scale. Magnified view 
of high intensity values in inset. TAG3 and TAG4 arrays have 
more downtags at a lower intensity than the tiling array. As 
expected, after antibody staining, intensities were amplified, 
and the distributions have longer tails.BMC Genomics 2009, 10:471 http://www.biomedcentral.com/1471-2164/10/471
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assays. We show that microarrays with reduced feature
size are equally able to assess DNA barcode abundance
when compared to barcode microarrays with larger fea-
tures. An increased sensitivity was also observed with
arrays with smaller features. They identified a previously
described target of tunicamycin with greater confidence
than the microarrays with greater feature size.
A widely held opinion is that next generation DNA
sequencing technologies will replace microarrays in gene
product detection [29]. However, microarrays can still
increase genome coverage by decreasing feature sizes to as
small as 1 μm because current microarray scanners can
detect probe intensities at sub-μm resolution. In theory,
such reductions in feature size could yield microarrays
with approximately 202 million probes/chip (compared
to 6.5 million using 5 μm features). Such probe densities
would rival next generation sequencing technologies in
terms of genome coverage.
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Supplementary information
Affymetrix microarray library files for the TAG3, TAG4
and tiling arrays are available at http://chemogenom
ics.med.utoronto.ca.
The supplementary figure displays the tiling array profiles
when the DMSO and tunicamycin treatment chips are




supplementary_data. A collection of processed microarray data corre-
sponding to the experiments from the manuscript. Experimental details 
are included in the individual file names within the collection.




Supplementary Figure. A figure displaying the tiling array profiles when 
the DMSO and tunicamycin treatment chips are hybridized with the bar-
codes alone or with the addition of gDNA.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-471-S2.JPEG]
TAG4 and tiling array data correlation after antibody staining Figure 3
TAG4 and tiling array data correlation after antibody 
staining. This example shows that the signal intensity for 
common barcodes between TAG4 and tiling arrays are highly 
correlated (r = 0.952), demonstrating that tiling arrays are as 
accurate as TAG4 arrays when determining relative signal 
intensity (compared to a DMSO reference on the same chip 
generation).
Table 2: Pearson correlation coefficients (r) across microarray 
generations without antibody (Ab) stain.
-- Ab Tiling TAG4 TAG3
TAG3 0.733 0.751 -
TAG4 0.927 -
Tiling -
TAG4 and tiling data are highly correlated, and this increases with 
antibody staining (compare Table 3). The opposite trend is observed 
between TAG3 and TAG4 or tiling, where antibody staining 
exacerbates the effect. Correlation of barcode intensity is vital 
because when both treatment and reference results from a single 
generation are correlated across generations, target identification 
should be almost identical.
Table 3: Pearson correlation coefficients (r) across microarray 
generations with antibody (Ab) stain.
+ Ab Tiling TAG4 TAG3
TAG3 0.605 0.642 -
TAG4 0.952 -
Tiling -
TAG4 and tiling data are highly correlated, and this increases with 
antibody staining (compare Table 2). The opposite trend is observed 
between TAG3 and TAG4 or tiling, where antibody staining 
exacerbates the effect.BMC Genomics 2009, 10:471 http://www.biomedcentral.com/1471-2164/10/471
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